Thursday 22 October 2026 · Edition of the day

Current editionPast editions →

The Skeptic's Daily

The day's biggest stories, taken apart. For each one: what is actually established, what is only asserted, the questions worth asking — and a plausibility score for the central claim, given everything currently known.

Stories
2
Average plausibility
81%
How to read the score
It rates how well the core claim is evidenced — not how important the story is, nor whether it is good or bad news.
01HealthAfrica

Nigeria confirms Ebola case as Kenya reports nine cases

Reporting links Nigeria's patient to travel from Uganda, while Kenya's government offers reassurance amid a US travel warning.

Nigeria's health ministry confirmed an Ebola case in Abuja in a woman who had travelled from Uganda, according to the Guardian. BBC describes the patient as a diplomat's wife who holidayed in Kampala. BBC also reports nine confirmed cases in Kenya, and France 24 reports preparations to coordinate a response as cases emerge in Nigeria and rise in Kenya.

What holds up

  • ✓BBC and the Guardian both report a Nigerian Ebola patient with recent travel to Uganda; the Guardian attributes confirmation to the health ministry.
  • ✓BBC and France 24 both report Ebola cases in Kenya, although only BBC supplies the nine-case figure.

What doesn't yet

  • ?The extracts do not establish where the Nigerian patient acquired the infection or any transmission link with Kenya.
  • ?Kenya's government reassurance is not accompanied by surveillance data demonstrating that transmission is under control.

Ask before you share

  • →What do current health-authority updates say about case counts and contact tracing?
  • →Is the patient's travel history being distinguished from a confirmed source of infection?

Sources & original reporting

  1. [1]BBC News · Published 21 Oct 2026 · bbc.co.uk
  2. [2]BBC News · Published 21 Oct 2026 · bbc.co.uk
  3. [3]The Guardian · Published 21 Oct 2026 · theguardian.com
  4. [4]France 24 · Published 21 Oct 2026 · france24.com
02HealthAfrica

Lead researcher says Guinea-Bissau newborn vaccine trial will not proceed

The Guardian reports the halt to a planned US-backed hepatitis B study after separately reporting a police raid on researchers' offices.

A planned hepatitis B vaccine trial involving newborns in Guinea-Bissau will not move forward there, its lead researcher said, according to the Guardian. The study was to receive CDC funding and had drawn global backlash. An earlier Guardian item reported that judicial police raided researchers' offices and seized hepatitis B vaccine doses.

What holds up

  • ✓The halt is attributed to lead researcher Frederik Schaltz-Buchholzer rather than an unidentified source.
  • ✓The earlier report attributes the police raid and vaccine seizure to officials.

What doesn't yet

  • ?Both supplied reports come from the Guardian; no regulator's decision or trial record is provided.
  • ?The extracts do not establish why the study was halted, whether it could proceed elsewhere, or whether the raid caused the halt.

Ask before you share

  • →Has the relevant authority formally confirmed the study's status?
  • →What were the grounds for the raid and the decision not to proceed?

Sources & original reporting

  1. [1]The Guardian · Published 21 Oct 2026 · theguardian.com
  2. [2]The Guardian · Published 20 Oct 2026 · theguardian.com